EMA — authorised 30 September 2008
- Marketing authorisation holder: BAYER PHARMA AG
- Status: approved
🇪🇺 Xarelto in European Union
EMA authorised Xarelto on 30 September 2008
Marketing authorisation
Xarelto in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Xarelto approved in European Union?
Yes. EMA authorised it on 30 September 2008.
Who is the marketing authorisation holder for Xarelto in European Union?
BAYER PHARMA AG holds the EU marketing authorisation.